Treatment of infertility in polycystic ovary syndrome

Posted by Chantel M. Research contributed by the US National Library of Medicine National Institutes of Health
The prevalence of childbearing age obesity is wide spreading in US, approximately, 50% of them are either overweight [body mass index (BMI) 25-29.9 kg/m(2)] or obese (BMI ≥ 30 kg/m(2)).
Treatment of infertility in polycystic ovary syndrome
Polycystic ovary syndrome (PCOS) is the most common cause of anovulatory infertility. According to the study by the University of New South Wales, posted in PubMed, lifestyle change alone is considered the first-line treatment for the management of infertile anovulatory PCOS women who are overweight or obese. First-line medical ovulation induction therapy to improve fertility outcomes is clomiphene citrate, whilst gonadotrophins, laparoscopic ovarian surgery or possibly metformin are second line in clomiphene citrate-resistant PCOS women. There is currently insufficient evidence to recommend aromatase inhibitors over that of clomiphene citrate in infertile anovulatory PCOS women in general or specifically in therapy naive or clomiphene citrate-resistant PCOS women. IVF/ICSI treatment is recommended either as a third-line treatment or in the presence of other infertility factors.


Chinese Secrets to Fatty Liver and Obesity Reversal
A Fabulous E book with Research based & Scientifically proven Efficacy 
To Treat Fatty Liver Diseases & Achieve Optimal Health & Loose Weight

For more information of Obesity effect on women health, click
http://thetruestoriesstories.blogspot.ca/p/women-and-obesity.html

For more information and health articles, please visit women's health http://thetruestoriesstories.blogspot.ca/